Why Do Steroids Make You Retain Water?

Steroids cause water retention primarily because they push your kidneys to reabsorb more sodium than they normally would, and water follows sodium wherever it goes in the body. This effect traces back to how steroid hormones interact with specific receptors in kidney tissue, tricking the organ into behaving as though your body needs to conserve salt and fluid. The details vary depending on whether you are taking prescription corticosteroids like prednisone or using anabolic steroids for muscle building, but the underlying story is the same: steroids tilt your body’s fluid balance toward holding on to more than it needs.

The Kidney’s Role in Steroid-Driven Fluid Retention

Your kidneys filter an enormous volume of blood every day, deciding what stays in the body and what gets flushed out as urine. Sodium is one of the most tightly regulated substances in that process. When sodium is reabsorbed back into your blood rather than excreted, water passively follows to keep the concentration balanced. That is the core mechanism behind steroid-related water retention: more sodium held means more water held.

Corticosteroids, the type most commonly prescribed for inflammation, can activate something called the mineralocorticoid receptor in your kidneys. This receptor normally responds to aldosterone, a hormone whose entire job is telling the kidneys to retain sodium. The problem is that cortisol and many synthetic corticosteroids fit into the same receptor. Your kidneys have an enzyme designed to prevent this mix-up by deactivating cortisol before it can reach the mineralocorticoid receptor, but when steroid levels are high enough, some of that excess cortisol escapes deactivation and directly switches on the sodium-retention signal.¹ The kidney essentially gets fooled into thinking aldosterone is sending the signal, and it starts pulling sodium and water back into circulation.

Beyond this receptor hijacking, glucocorticoids affect sodium balance through additional routes. They can increase the production of mineralocorticoids in the adrenal glands, and they stimulate sodium reabsorption through their own dedicated glucocorticoid receptors, which are also present in kidney tissue. Research has shown that an enzyme called 11βHSD1 generates active glucocorticoid inside the kidney itself, and when this enzyme fails to dial down during periods of high salt intake, the result is salt-sensitive fluid retention and elevated blood pressure.² In other words, the kidney has multiple pathways through which steroids can drive sodium and water retention, and high-dose steroid therapy can activate several of them at once.

Why Some Steroids Cause More Bloating Than Others

Not all corticosteroids are created equal when it comes to water retention. The chemical structure of a steroid molecule determines how strongly it activates the mineralocorticoid receptor versus the glucocorticoid receptor. Two people taking different steroids at equivalent anti-inflammatory doses can have very different experiences with puffiness and swelling.

Lab studies comparing a range of therapeutic steroids have mapped out which structural features increase mineralocorticoid activity and which suppress it. Adding a fluorine atom at certain positions on the molecule, for instance at the 9-alpha or 6-alpha position, ramps up mineralocorticoid potency, meaning more sodium retention. Meanwhile, modifications like adding a bulky group at position 16 tend to strip away the mineralocorticoid effects while preserving anti-inflammatory power. Steroids like betamethasone and budesonide have been identified as having almost no mineralocorticoid activity in cell-based assays, making them far less likely to cause fluid retention compared to, say, fludrocortisone or older formulations with strong mineralocorticoid overlap.³

This is why doctors sometimes switch patients from one corticosteroid to another if fluid retention becomes a problem. Prednisone, one of the most widely prescribed oral corticosteroids, has moderate mineralocorticoid activity. Dexamethasone and methylprednisolone, by contrast, have significantly less. Hydrocortisone, which is chemically identical to cortisol, has relatively high mineralocorticoid effects and is more likely to cause noticeable bloating at therapeutic doses. When your doctor picks a steroid, the trade-off between anti-inflammatory strength, mineralocorticoid side effects, and how long the drug stays active in your body all factor into the choice.

The Blood Pressure Problem

Water retention from steroids is not just a cosmetic annoyance. Holding onto extra fluid raises your blood volume, and higher blood volume pushes your blood pressure up. This is one reason why long-term steroid use is strongly associated with hypertension. But the blood pressure effects go beyond simple fluid overload.

Research into glucocorticoid-induced hypertension has identified several mechanisms working in parallel. Glucocorticoids increase the liver’s production of a protein called angiotensinogen, which feeds into the renin-angiotensin system and amplifies signals that constrict blood vessels. At the same time, steroids suppress several of the body’s natural blood-pressure-lowering systems, including those involving nitric oxide, prostaglandins, and the kallikrein-kinin pathway. The net result is that blood vessels become more reactive to substances that tighten them, while the brakes that normally keep pressure in check are weakened.⁴ Steroid-related hypertension is therefore a combination of extra fluid, tighter vessels, and blunted counter-regulatory systems, not just waterlogging alone.

Exogenous corticosteroids also alter the renin-angiotensin-aldosterone system (RAAS) in complex ways. While they tend to suppress plasma renin activity and change aldosterone levels, they still drive sodium and water reabsorption through direct mineralocorticoid receptor activation.⁵ For people already managing high blood pressure, adding a corticosteroid can make control significantly harder. This is one of the main reasons doctors aim for the lowest effective dose and shortest possible course when prescribing these medications.

Anabolic Steroids and Water Retention

The water retention story changes somewhat when the steroids in question are anabolic-androgenic steroids, the kind used by bodybuilders and athletes. These are synthetic derivatives of testosterone, and they promote water retention through a somewhat different set of pathways than corticosteroids.

Androgens enhance salt reabsorption and water handling in the proximal tubule of the kidney and stimulate overall kidney volume in males.⁶ This means that testosterone and its synthetic analogues directly act on kidney tissue to shift the balance toward retaining fluid. Many anabolic steroids also convert to estrogen through an enzyme called aromatase, and that estrogen can further promote water retention. This is why bodybuilders using steroids like testosterone or dianabol often report a “watery” or “puffy” look, particularly around the face and midsection, and why some use anti-estrogen drugs in an attempt to counteract the effect.

Different anabolic compounds vary in how much water they cause you to hold. Steroids that aromatize heavily, converting readily to estrogen, tend to produce more visible bloating. Those that do not aromatize, or that have been chemically modified to resist conversion, generally cause less. This distinction matters in the bodybuilding world because water retention obscures muscle definition. Competitors typically switch to non-aromatizing compounds in the weeks before a show to shed subcutaneous water and appear leaner, though this practice carries its own health risks.

How Sex Hormones Change the Picture

The degree of fluid retention from steroids is not the same in everyone, and biological sex is one of the factors that shifts the balance. Estrogen and testosterone have opposing effects on several components of the body’s fluid regulation system.

Estrogen tends to suppress several elements of the RAAS that drive sodium retention: it lowers renin levels, reduces the activity of the enzyme that generates angiotensin II, decreases the density of receptors that angiotensin II acts on, and reduces aldosterone production. It also boosts counter-regulatory systems like natriuretic peptides, which promote sodium excretion. Progesterone adds another layer of protection by competing with aldosterone for the mineralocorticoid receptor, effectively blocking some of the sodium-retention signal. Testosterone, on the other hand, appears to do the opposite in key respects, increasing renin levels and the activity of angiotensin-converting enzyme.⁷

What this means in practical terms is that premenopausal women may have some built-in buffering against steroid-induced fluid retention compared to men, thanks to higher estrogen and progesterone levels. After menopause, when those protective effects diminish, women may become more susceptible. And for men, the baseline androgenic environment already tilts the system toward sodium retention, so adding exogenous steroids of any type stacks an additional load onto a system that is already leaning in that direction.

What Happens When You Stop Taking Steroids

A common expectation is that water retention will resolve quickly once you stop taking steroids. For short courses, that is generally true: the kidneys adjust back to normal sodium handling within days, and the excess fluid is excreted. You may notice more frequent urination for a brief period as your body dumps the extra water. But the picture gets more complicated with longer steroid courses or abrupt discontinuation.

Rebound edema, where swelling temporarily worsens after stopping steroids, is a recognized phenomenon. The body adapts to the presence of steroids by adjusting various counter-regulatory systems, and when the drug is suddenly removed, those systems need time to recalibrate. Research in surgical models has shown that a tapering protocol, gradually reducing the steroid dose rather than stopping cold, significantly reduces rebound edema compared to abrupt withdrawal.⁸ This is one of several reasons doctors typically taper corticosteroids after courses lasting more than a week or two, rather than having you simply stop.

The adrenal glands also need time to resume normal cortisol production after being suppressed by exogenous steroids. During this recovery window, the body’s fluid regulation can be unpredictable. Some people experience temporary swings in fluid balance, alternating between feeling puffy and feeling depleted, before things settle. The duration of this adjustment period depends on the steroid used, the dose, and how long the course lasted. For people who have been on moderate to high doses for months, full normalization can take weeks.

Practical Ways to Manage the Bloating

If you are on a steroid course and dealing with uncomfortable water retention, a few strategies can help without undermining the medication’s purpose.

Reduce sodium intake: Since steroids amplify sodium retention, cutting back on salt gives the kidneys less raw material to hold onto. Processed foods, restaurant meals, and canned goods are the biggest sources for most people.
Stay hydrated: This sounds counterintuitive, but drinking adequate water signals your kidneys that there is no need to aggressively conserve fluid. Chronic mild dehydration can actually worsen retention.
Elevate swollen areas: If fluid pools in your legs or ankles, elevating them above heart level for stretches during the day helps the fluid redistribute and eventually get excreted.
Move regularly: Physical activity supports lymphatic drainage and venous return, helping to prevent fluid from pooling in the extremities.
Talk to your doctor about the steroid choice: If fluid retention is severe, switching to a corticosteroid with lower mineralocorticoid activity or adjusting the dose may be an option.

Diuretics are sometimes prescribed alongside steroids in cases where fluid retention is medically problematic, such as when it worsens heart failure or causes dangerous blood pressure spikes. But using over-the-counter diuretics or “water pills” on your own while taking steroids is not a good idea without medical guidance, because the electrolyte shifts involved can compound those already caused by the steroid itself.

Why the “Moon Face” Happens

One of the most visible and distressing effects of corticosteroid therapy is the characteristic rounding of the face, commonly called moon face or Cushingoid appearance. People sometimes assume this is just water retention in the face, but the reality is a bit more involved. Moon face results from a combination of fluid redistribution and fat redistribution. Corticosteroids promote the deposition of fat in specific areas: the face, the back of the neck, and the trunk, while simultaneously thinning fat in the limbs. The fluid retention component adds puffiness on top of this altered fat distribution, creating the rounded appearance.

The fat redistribution piece does not resolve as quickly as the water component. When you stop steroids, the fluid-related puffiness in the face may improve within a week or two, but the fat deposits can take months to normalize. This distinction frustrates many patients who expect the cosmetic effects to reverse as soon as the medication is done. Understanding that two separate processes are at play helps set realistic expectations for recovery.

Steroid Eye Drops and Local Fluid Effects

Not all steroids are taken systemically. Steroid eye drops, inhaled steroids for asthma, and topical steroid creams are common, and people sometimes wonder whether these can cause water retention too. The answer depends heavily on how much of the steroid reaches the bloodstream.

Inhaled corticosteroids used at standard doses for asthma or COPD rarely cause meaningful systemic fluid retention, because the dose that reaches the blood is very small. The same is true for most topical skin applications. Steroid eye drops like dexamethasone do have local tissue effects: research on eye tissue cells has shown that dexamethasone treatment increases the accumulation of extracellular matrix components like fibronectin and glycosaminoglycans, which can affect fluid dynamics within the eye itself.⁹ This local tissue remodeling can impair fluid drainage in the eye and contribute to elevated eye pressure, a well-known risk of long-term steroid eye drop use. But this is a localized effect, not the kind of whole-body water retention that oral or injected steroids produce.

The exception is when local steroids are used at very high doses, over large surface areas, or for extended periods. Potent topical steroids applied liberally over large patches of skin can absorb enough to produce systemic effects, including fluid retention. Children are particularly susceptible because of their higher skin-surface-area-to-body-weight ratio. For most people using a standard steroid inhaler or a tube of hydrocortisone cream on a small rash, however, systemic water retention is not a practical concern.